Reference : Antifracture efficacy and safety of once-yearly Zoledronic acid 5mg in men with osteo...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Public health, health care sciences & services
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/88516
Antifracture efficacy and safety of once-yearly Zoledronic acid 5mg in men with osteoporosis: a prospective, randomized, controlled trial
English
Boonen, Steven [ > > ]
Su, Guoqin [ > > ]
Incera, Elodie [ > > ]
Orwoll, Eric [ > > ]
Kaufman, Jean-Marc [ > > ]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Rizzoli, René [ > > ]
Lippuner, Kurt [ > > ]
Vanderschueren, Dirk [ > > ]
Bucci-Rechtweg, Christina [ > > ]
Antunez, Oscar [ > > ]
Papanastasiou, Phil [ > > ]
Mar-2011
Osteoporosis International
Springer Science & Business Media B.V.
22
Suppl.1
S112
Yes (verified by ORBi)
No
International
0937-941X
1433-2965
Godalming
United Kingdom
European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF
du 23 mars 2011 au 26 mars 2011
International Osteoporosis Foundation and National Osteoporosis Foundation 2011
Valencia
Spain
http://hdl.handle.net/2268/88516

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
OC35.pdfPublisher postprint39.72 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.